CollabRx, Inc. (CLRX) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 43 transactions totaling $916.5K, demonstrating a bearish sentiment with -$874.9K in net insider flow. The most recent transaction on Jun 23, 2014 involved a purchase of 3,000 shares valued at $5.9K.
No significant insider buying has been recorded for CLRX in the recent period.
No significant insider selling has been recorded for CLRX in the recent period.
Based on recent SEC filings, insider sentiment for CLRX is bearish with an Insider Alignment Score of 2/100 and a net flow of -$874.9K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CollabRx, Inc. (CLRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading CLRX stock, having executed 43 transactions in the past 90 days. The most active insider is Participations Alcatel-lucent (Executive), who has made 38 transactions totaling $895.7K.
Get notified when executives and directors at CLRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 23, 2014 | Karis James | Executive | Purchase | 3,000 | $1.96 | $5.9K | |
| Jun 23, 2014 | Muscari Carl | Executive | Purchase | 2,500 | $1.95 | $4.9K | |
| Jan 27, 2014 | Mika Thomas | Executive | Option Exercise | 30,417 | $N/A | $0 | |
| Nov 15, 2013 | Muscari Carl | Executive | Purchase | 1,300 | $3.85 | $5.0K | |
| Mar 26, 2013 | Muscari Carl | Executive | Purchase | 1,540 | $3.25 | $5.0K | |
| Oct 5, 2012 | Alcatel-lucent Participations | Executive | Sale | 1,000 | $4.04 | $4.0K | |
| Oct 5, 2012 | Alcatel-lucent Participations | Executive | Sale | 630 | $4.01 | $2.5K | |
| Oct 5, 2012 | Alcatel-lucent Participations | Executive | Sale | 5,000 | $4.40 | $22.0K | |
| Oct 5, 2012 | Alcatel-lucent Participations | Executive | Sale | 2,400 | $4.37 | $10.5K | |
| Oct 5, 2012 | Alcatel-lucent Participations | Executive | Sale | 200 | $4.36 | $872 | |
| Oct 5, 2012 | Alcatel-lucent Participations | Executive | Sale | 1,000 | $4.35 | $4.3K | |
| Oct 5, 2012 | Alcatel-lucent Participations | Executive | Sale | 1,832 | $4.33 | $7.9K | |
| Oct 5, 2012 | Alcatel-lucent Participations | Executive | Sale | 2,000 | $4.32 | $8.6K | |
| Oct 5, 2012 | Alcatel-lucent Participations | Executive | Sale | 1,600 | $4.30 | $6.9K | |
| Oct 5, 2012 | Alcatel-lucent Participations | Executive | Sale | 800 | $4.29 | $3.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 38 | $895.7K | 97.7% |
Purchase(P) | 4 | $20.8K | 2.3% |
Exercise(M) | 1 | $0 | 0.0% |
Insider selling pressure at CollabRx, Inc. has increased, with 4 insiders executing 43 transactions across all time. Total sales of $895.7K significantly outpace purchases of $20.8K, resulting in a net outflow of $874.9K. This selling activity appears largely discretionary, which may warrant closer attention from investors.